J.P. Morgan Healthcare Conference Special: Dealmaker of the Year 2024 (Part 01)

J.P. Morgan Healthcare Conference Special: Dealmaker of the Year 2024 (Part 01)

Using DealForma insights, PharmaShots names Roche Dealmaker of the Year 2024 (Part 1), leading with 38 deals despite lower overall M&A values. Read it here

DealForma Research

Explore More
Biopharma Therapeutics and Platforms M&A - 2025 Review

Biopharma Therapeutics and Platforms M&A – 2025 Review

Biopharma Therapeutics and Platforms R&D Partnerships - 2025 Review

Biopharma Therapeutics and Platforms R&D Partnerships – 2025 Review

Dermatology M&A - 2024-2025 Review

Dermatology M&A – 2024-2025 Review

All of this by stage, disease indication, modality, target…

Schedule your Demo
+ 0 k
Licensing Deals
+ 0 k
M&A
+ 0 k
Other Deals
+ 0 k
Funding Rounds
+ 0 k
Company Profiles
+ 0 k
Drug Sales Figures
DealForma Logo

DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.

Linkedin

Database

Company

Comparisons

Website Design by Once Interactive